Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Health Sciences Acquisitions Corporation 2 (HSAQ) stock

Learn how to easily invest in Health Sciences Acquisitions Corporation 2 stock.

Health Sciences Acquisitions Corporation 2
NASDAQ: HSAQ - USD
SHELL COMPANIES
$9.99
+$0.06 (+0.60%)

Health Sciences Acquisitions Corporation 2 is a shell companies business based in the US. Health Sciences Acquisitions Corporation 2 shares (HSAQ) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Health Sciences Acquisitions Corporation 2

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HSAQ – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Health Sciences Acquisitions Corporation 2 stock price (NASDAQ: HSAQ)

Use our graph to track the performance of HSAQ stocks over time.

Health Sciences Acquisitions Corporation 2 shares at a glance

Information last updated 2021-07-23.
Latest market close$10.27
52-week range$9.74 - $14.66
50-day moving average $10.11
200-day moving average $11.11
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Health Sciences Acquisitions Corporation 2 shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Health Sciences Acquisitions Corporation 2 stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Health Sciences Acquisitions Corporation 2 price performance over time

Historical closes compared with the close of $10.27 from 2021-05-28

1 week (2021-07-17) N/A
1 month (2021-06-28) 2.70%
3 months (2021-04-28) -3.30%
6 months (2021-01-24) N/A
1 year (2020-07-24) N/A
2 years (2019-07-24) N/A
3 years (2018-07-24) N/A
5 years (2016-07-24) N/A

Health Sciences Acquisitions Corporation 2 financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM -9999999%
Profit margin 0%
Book value $0.24
Market capitalisation $204.5 million

TTM: trailing 12 months

Shorting Health Sciences Acquisitions Corporation 2 shares

There are currently 3,999 Health Sciences Acquisitions Corporation 2 shares held short by investors – that's known as Health Sciences Acquisitions Corporation 2's "short interest". This figure is 388.3% up from 819 last month.

There are a few different ways that this level of interest in shorting Health Sciences Acquisitions Corporation 2 shares can be evaluated.

Health Sciences Acquisitions Corporation 2's "short interest ratio" (SIR)

Health Sciences Acquisitions Corporation 2's "short interest ratio" (SIR) is the quantity of Health Sciences Acquisitions Corporation 2 shares currently shorted divided by the average quantity of Health Sciences Acquisitions Corporation 2 shares traded daily (recently around 39990). Health Sciences Acquisitions Corporation 2's SIR currently stands at 0.1. In other words for every 100,000 Health Sciences Acquisitions Corporation 2 shares traded daily on the market, roughly 100 shares are currently held short.

However Health Sciences Acquisitions Corporation 2's short interest can also be evaluated against the total number of Health Sciences Acquisitions Corporation 2 shares, or, against the total number of tradable Health Sciences Acquisitions Corporation 2 shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Health Sciences Acquisitions Corporation 2's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Health Sciences Acquisitions Corporation 2 shares in existence, roughly 0 shares are currently held short) or 0.0003% of the tradable shares (for every 100,000 tradable Health Sciences Acquisitions Corporation 2 shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Health Sciences Acquisitions Corporation 2.

Find out more about how you can short Health Sciences Acquisitions Corporation 2 stock.

Health Sciences Acquisitions Corporation 2 share dividends

We're not expecting Health Sciences Acquisitions Corporation 2 to pay a dividend over the next 12 months.

Health Sciences Acquisitions Corporation 2 overview

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. .

Health Sciences Acquisitions Corporation 2 in the news

There are no recent company news

Frequently asked questions

What percentage of Health Sciences Acquisitions Corporation 2 is owned by insiders or institutions?
Currently 21.907% of Health Sciences Acquisitions Corporation 2 shares are held by insiders and 58.846% by institutions.
When does the fiscal year end for Health Sciences Acquisitions Corporation 2?
Health Sciences Acquisitions Corporation 2's fiscal year ends in December.
Where is Health Sciences Acquisitions Corporation 2 based?
Health Sciences Acquisitions Corporation 2's address is: 40 10th Avenue, New York, NY, United States, 10014
What is Health Sciences Acquisitions Corporation 2's ISIN number?
Health Sciences Acquisitions Corporation 2's international securities identification number is: KYG4411D1097

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site